Evidence map›Paper›PMID 37723312›Full record

ArticleOncogene2023

Correction: IL6 derived from cancer-associated fibroblasts promotes chemoresistance via CXCR7 in esophageal squamous cell carcinoma.

Y Qiao, C Zhang, A Li, D Wang, Z Luo, Y Ping, B Zhou, S Liu, H Li, D Yue and 13 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Oncogene, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Y Qiao *Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
C Zhang *Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
A LiBiotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
D WangBiotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Z LuoBiotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Y PingBiotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
B ZhouBiotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
S LiuBiotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
H LiBiotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
D YueBiotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Z ZhangBiotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
X ChenBiotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Z ShenBiotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
J LianBiotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Y LiBiotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
S WangBiotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
F LiBiotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
L HuangBiotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
L WangCancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
B ZhangDepartment of Hematology/Oncology, School of Medicine, Northwestern University, Chicago, IL, USA.
J YuDepartment of Internal Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH, USA.
Z QinMedical Research Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Y ZhangBiotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. yizhang@zzu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.